is victoza a glp 1 agonist (Liraglutide) Victoza vs. Ozempic: Choosing the

If youre working in biopharma, healthcare strategy, or wellness innovation, this is one review worth reading

Meanwhile, Wegovy is facing tough competition from Eli Lilly's weight-loss therapy Zepbound (tirzepatide), which outperformed its rival in the head-to-head SURMOUNT-5 trial

So far, studies on these new, multi-agonist drugs suggest that activating multiple receptors may lead to greater weight loss than GLP-1 alone

Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes